UA37251C2 - Лекарственное средство для лечения или профилактики вирусной инфекции гепатита в и способ лечения вирусной инфекции гепатита в - Google Patents

Лекарственное средство для лечения или профилактики вирусной инфекции гепатита в и способ лечения вирусной инфекции гепатита в

Info

Publication number
UA37251C2
UA37251C2 UA93004171A UA93004171A UA37251C2 UA 37251 C2 UA37251 C2 UA 37251C2 UA 93004171 A UA93004171 A UA 93004171A UA 93004171 A UA93004171 A UA 93004171A UA 37251 C2 UA37251 C2 UA 37251C2
Authority
UA
Ukraine
Prior art keywords
viral hepatitis
prevention
substance
treatment
treating
Prior art date
Application number
UA93004171A
Other languages
English (en)
Ukrainian (uk)
Inventor
Філліп Аллен Фурман
Филлип Аллен Фурман
Джордж Роберт Пеінтер
Джордж Роберт Пейнтер
Original Assignee
Дзе Веллкам Фаундейшн Лімітед
Дзе Веллкам Фаундейшн Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дзе Веллкам Фаундейшн Лімітед, Дзе Веллкам Фаундейшн Лимитед filed Critical Дзе Веллкам Фаундейшн Лімітед
Publication of UA37251C2 publication Critical patent/UA37251C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Настоящее изобретение относится к применению производных 1-(2-гидроксиметил-1,3-оксатиолан-5-ил)цитозина и их физиологически функциональных производных для лечения инфекций вируса гепатита В.
UA93004171A 1991-05-02 1992-05-01 Лекарственное средство для лечения или профилактики вирусной инфекции гепатита в и способ лечения вирусной инфекции гепатита в UA37251C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919109506A GB9109506D0 (en) 1991-05-02 1991-05-02 Therapeutic nucleosides
PCT/GB1992/000803 WO1992019246A1 (en) 1991-05-02 1992-05-01 Use of a 1,3-oxathiolan derivative for the treatment of hepatitis b infection

Publications (1)

Publication Number Publication Date
UA37251C2 true UA37251C2 (ru) 2001-05-15

Family

ID=10694346

Family Applications (1)

Application Number Title Priority Date Filing Date
UA93004171A UA37251C2 (ru) 1991-05-02 1992-05-01 Лекарственное средство для лечения или профилактики вирусной инфекции гепатита в и способ лечения вирусной инфекции гепатита в

Country Status (14)

Country Link
EP (1) EP0583274A1 (ru)
JP (1) JPH06506929A (ru)
AU (1) AU1662092A (ru)
CA (1) CA2102120A1 (ru)
GB (1) GB9109506D0 (ru)
IE (1) IE921363A1 (ru)
IL (1) IL101757A0 (ru)
MX (1) MX9203214A (ru)
MY (1) MY137298A (ru)
PT (1) PT100435B (ru)
RU (1) RU2104700C1 (ru)
UA (1) UA37251C2 (ru)
WO (1) WO1992019246A1 (ru)
ZA (1) ZA923185B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5684164A (en) * 1988-04-11 1997-11-04 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
US5466806A (en) * 1989-02-08 1995-11-14 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
GB9110874D0 (en) * 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
ZA923640B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
CA2355712C (en) 1998-12-23 2009-03-17 Shire Biochem Inc. Antiviral nucleoside analogues

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5159067A (en) * 1987-01-28 1992-10-27 University Of Georgia Research Foundation Inc. 5'-Diphosphohexose nucleoside pharmaceutical compositions
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
JPH04501854A (ja) * 1989-05-15 1992-04-02 アメリカ合衆国 肝炎の治療方法
US5204466A (en) * 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds

Also Published As

Publication number Publication date
RU2104700C1 (ru) 1998-02-20
GB9109506D0 (en) 1991-06-26
MX9203214A (es) 1992-07-01
PT100435A (pt) 1993-09-30
WO1992019246A1 (en) 1992-11-12
IE921363A1 (en) 1992-11-04
CA2102120A1 (en) 1992-11-03
MY137298A (en) 2009-01-30
EP0583274A1 (en) 1994-02-23
JPH06506929A (ja) 1994-08-04
PT100435B (pt) 1999-08-31
ZA923185B (en) 1993-11-01
IL101757A0 (en) 1992-12-30
AU1662092A (en) 1992-12-21

Similar Documents

Publication Publication Date Title
DE69232649D1 (de) Verwendung von 5-fluoro-2'-deoxy-3'-thiacytidin zur behandlung von hepatitis b
ES2051641A1 (es) Procedimientos para la preparacion de compuestos derivados de tiourea.
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
HU9302496D0 (en) Method for producing anti-viral nucleoside combinations and one for preparing medical preparatives containing said compounds
MY121548A (en) Compounds and methods for the treatment of cancer
DE69830751D1 (de) Polyaromatische Verbindungen zur Behandlung von Herpes-Infektionen
DE69526937D1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
ES2125976T3 (es) Otros derivados de indol con accion antiviral.
MY127808A (en) Use of dideoxy nucleoside analogues in the treatment of viral infections
ATE303154T1 (de) Verwendung von einem trifluridin derivat allein oder in kombination mit einem thymidin- phosphorylase-hemmer zur behandlung von hiv
ATE79031T1 (de) Verwendung von ketonderivaten zur behandlung von depressionen.
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
UA37251C2 (ru) Лекарственное средство для лечения или профилактики вирусной инфекции гепатита в и способ лечения вирусной инфекции гепатита в
AP9801286A0 (en) Therapeutic compounds.
ZA991029B (en) Composition and methods for treatment of hiv infections.
DE69232417D1 (de) Michellamine zur verwendung als antivirale wirkstoffe, zusammensetzung und behandlungsverfahren
NO970573D0 (no) Ylidenforbindelser og deres fremstilling
MY124071A (en) Treatment of viral disease in swine
ZA858237B (en) Ing 1-b-d-ribofuranosyl-1,2,4-triazole-3-carboxamine method of medical treatment of human viral diseases utiliz
ATE204476T1 (de) Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazi e zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem
ES2014042A6 (es) Un procedimiento para la preparacion de una composicion de 1-(2'-desoxi -2' fluor -b- d- arabinofuranosil) -5-etiluracilo.
ATE255417T1 (de) Verwendung von bradykinin-antagonisten zur behandlung von viruserkrankungen
AU630249B2 (en) Prevention of glycoprotein enveloped virus infectivity by quinolyloxazole-2-ones
NO982151D0 (no) Hemoregulatoriske forbindelser
DE60002172T2 (de) Verwendung von (1r,4s)-4-(6-amino-9h-purin-9-yl)-2-cyclopenten-1-methanol in hbv